Bionano Genomics (BNGO) Current Leases (2021 - 2025)
Historic Current Leases for Bionano Genomics (BNGO) over the last 5 years, with Q3 2025 value amounting to $1.0 million.
- Bionano Genomics' Current Leases fell 4759.71% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 4759.71%. This contributed to the annual value of $3.0 million for FY2024, which is 3828.02% up from last year.
- Latest data reveals that Bionano Genomics reported Current Leases of $1.0 million as of Q3 2025, which was down 4759.71% from $1.3 million recorded in Q2 2025.
- Over the past 5 years, Bionano Genomics' Current Leases peaked at $3.0 million during Q4 2024, and registered a low of $1.0 million during Q3 2025.
- For the 5-year period, Bionano Genomics' Current Leases averaged around $1.9 million, with its median value being $2.0 million (2023).
- As far as peak fluctuations go, Bionano Genomics' Current Leases soared by 5405.59% in 2022, and later tumbled by 4759.71% in 2025.
- Bionano Genomics' Current Leases (Quarter) stood at $1.5 million in 2021, then soared by 54.06% to $2.3 million in 2022, then fell by 4.29% to $2.2 million in 2023, then surged by 38.28% to $3.0 million in 2024, then plummeted by 65.73% to $1.0 million in 2025.
- Its Current Leases was $1.0 million in Q3 2025, compared to $1.3 million in Q2 2025 and $1.6 million in Q1 2025.